Frank Takkinen
Stock Analyst at Lake Street
(0.89)
# 3,656
Out of 4,829 analysts
58
Total ratings
27.27%
Success rate
-19.6%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELUT Elutia | Maintains: Buy | $10 → $8 | $2.04 | +293.12% | 3 | May 9, 2025 | |
| SGHT Sight Sciences | Maintains: Hold | $2.5 → $3 | $3.08 | -2.60% | 4 | May 9, 2025 | |
| NOTV Inotiv | Maintains: Buy | $6 → $5 | $1.96 | +155.10% | 7 | May 8, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $19 → $14 | $4.77 | +193.50% | 7 | Apr 8, 2025 | |
| LNSR LENSAR | Downgrades: Hold | $16 → $15 | $13.93 | +7.68% | 2 | Mar 24, 2025 | |
| HYPR Hyperfine | Initiates: Buy | $1.5 | $0.74 | +101.61% | 1 | Mar 24, 2025 | |
| AXGN Axogen | Initiates: Buy | $30 | $11.37 | +163.97% | 1 | Mar 17, 2025 | |
| CLBT Cellebrite DI | Maintains: Buy | $17 → $26 | $19.80 | +31.35% | 3 | Feb 14, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $17 → $30 | $14.11 | +112.62% | 4 | Jan 21, 2025 | |
| KRMD KORU Medical Systems | Maintains: Buy | $4 → $5 | $3.13 | +59.74% | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.21 | +375.06% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.60 | +92.31% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.08 | +640.74% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $28.91 | +3.77% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $3.37 | +256.08% | 1 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $1.69 | +255.03% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.13 | +87.79% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $12.95 | -7.30% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $305 → $350 | $151.25 | +131.40% | 1 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $5 | $3.60 | +38.89% | 3 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $1.16 | +675.86% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $2.20 | +627.27% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.68 | +1,253.57% | 2 | Jan 18, 2023 |
Elutia
May 9, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $2.04
Upside: +293.12%
Sight Sciences
May 9, 2025
Maintains: Hold
Price Target: $2.5 → $3
Current: $3.08
Upside: -2.60%
Inotiv
May 8, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $1.96
Upside: +155.10%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $4.77
Upside: +193.50%
LENSAR
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $13.93
Upside: +7.68%
Hyperfine
Mar 24, 2025
Initiates: Buy
Price Target: $1.5
Current: $0.74
Upside: +101.61%
Axogen
Mar 17, 2025
Initiates: Buy
Price Target: $30
Current: $11.37
Upside: +163.97%
Cellebrite DI
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $19.80
Upside: +31.35%
ClearPoint Neuro
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $14.11
Upside: +112.62%
KORU Medical Systems
Jan 14, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $3.13
Upside: +59.74%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $4.21
Upside: +375.06%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $2.60
Upside: +92.31%
Aug 13, 2024
Maintains: Buy
Price Target: $14 → $8
Current: $1.08
Upside: +640.74%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $28.91
Upside: +3.77%
Jun 4, 2024
Initiates: Buy
Price Target: $12
Current: $3.37
Upside: +256.08%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $1.69
Upside: +255.03%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.13
Upside: +87.79%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $12.95
Upside: -7.30%
Aug 2, 2023
Maintains: Buy
Price Target: $305 → $350
Current: $151.25
Upside: +131.40%
Jul 19, 2023
Maintains: Buy
Price Target: $2.5 → $5
Current: $3.60
Upside: +38.89%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $1.16
Upside: +675.86%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $2.20
Upside: +627.27%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.68
Upside: +1,253.57%